Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

Item
http://www.wikidata.org/entity/Q48534634
Comparative pharmacology of a new recombinant FSH expressed by a human cell line.The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.How to personalize ovarian stimulation in clinical practiceAge-specific serum anti-Müllerian hormone concentration in Japanese women and its usefulness as a predictor of the ovarian response.Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer.Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.Individualized controlled ovarian stimulation in expected poor-responders: an update.Derailing individualized ovarian stimulation.Delayed Start Protocol with Gonadotropin-releasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Double-blinded, Clinical Trial
P2860

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

Item
http://www.wikidata.org/entity/Q48534634
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Individualized versus conventi ...... phase 3 noninferiority trial.
@en
Individualized versus conventi ...... phase 3 noninferiority trial.
@nl
type
label
Individualized versus conventi ...... phase 3 noninferiority trial.
@en
Individualized versus conventi ...... phase 3 noninferiority trial.
@nl
prefLabel
Individualized versus conventi ...... phase 3 noninferiority trial.
@en
Individualized versus conventi ...... phase 3 noninferiority trial.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Individualized versus conventi ...... phase 3 noninferiority trial.
@en
P2093
P304
P31
P356
10.1016/J.FERTNSTERT.2016.10.033
P407
P433
P478
P50
P577
P698
P921